Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Wilms Tumor 1Triple Negative Breast Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasm Metastasis 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Histiocytosis, Langerhans-Cell 1Hepatoblastoma 1Glioma 1Ependymoma 1

Interventions

pembrolizumab 6Nivolumab 5Magnetic Resonance Spectroscopy 4fludarabine 3Sirolimus 3Radiotherapy 3Methods 3Gemcitabine 3Early Intervention, Educational 3Drug Therapy 3Biopsy 3spartalizumab 2epacadostat 2atezolizumab 2X-Rays 2Topotecan 2Surveys and Questionnaires 2Specimen Handling 2Palliative Care 2Nuclear Medicine Department, Hospital 2Ipilimumab 2Interleukin-2 2Educational Status 2Dasatinib 2Cyclophosphamide 2Carboplatin 2vocimagene amiretrorepvec 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Pharmacogenomic Variants × Gastrointestinal × Clear all
NCT03291938 2020-11-24

IACS-010759 in Advanced Cancers

M.D. Anderson Cancer Center

Phase 1 Completed
29 enrolled
BreastGastrointestinalLymphoid

Lymphoma, Neoplasm Metastasis, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡